Trial
NCT05885074
Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Obesity
Intervention
Empagliflozin Arm
Why stopped
Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-07